<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03071601</url>
  </required_header>
  <id_info>
    <org_study_id>CHM-2016-S2/04</org_study_id>
    <nct_id>NCT03071601</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Topical Analgesia for Laceration Repair in the Emergency Department</brief_title>
  <official_title>Prospective Evaluation of Topical Analgesia Using a Lidocaine/Prilocaine Cream for Laceration Repair in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier le Mans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier le Mans</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if topical analgesia using a lidocaine and
      prilocaine cream improves pain scores compared to the usual local anesthesia using
      subcutaneous 1% lidocaine and adrenalin injected near the laceration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized open clinical trial conducted in two high volume emergency
      departments in France.

      Adult patients presenting for laceration repair by suture will be allocated, after consent is
      obtained, on a one to one basis using a randomisation by minimisation method.

      126 patients are expected to enrol in the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 2, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum pain</measure>
    <time_frame>60 minutes</time_frame>
    <description>Maximum pain on the numerical pain scale (0-10) during laceration management (anesthesia, exploration and suture of the laceration).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>60 minutes</time_frame>
    <description>Patient satisfaction relating to the pain management measured on a four point Likert scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Topical anesthesia failure rate</measure>
    <time_frame>60 minutes</time_frame>
    <description>Percentage of patients in the intervention group who required additional anesthesia by subcutaneous injection of Lidocaine/Epinephrine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain management during the various stages of care</measure>
    <time_frame>60 minutes</time_frame>
    <description>Maximum pain measured on the numerical pain scale (0-10) measured on admission to the emergency department, during the wait for laceration treatment, during the wound cleansing for the intervention group and during anesthesia for the control group, during suture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Management duration</measure>
    <time_frame>60 minutes</time_frame>
    <description>Mean duration of management between admission to the emergency department and discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>15 days</time_frame>
    <description>Evaluation of adverse effects due to the anesthesia technique (e.g. allergic reactions) by a telephone interview 15 days after initial management</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound healing</measure>
    <time_frame>15 days</time_frame>
    <description>Evaluation of the quality of wound healing during a telephone interview by identifying signs of wound infection and/or wound reopening.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Pain, Acute</condition>
  <condition>Laceration</condition>
  <arm_group>
    <arm_group_label>Topical anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical anesthesia using a cream containing 2.5% Lidocaine and 2.5% Prilocaine applied for at least 30 minutes before laceration repair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subcutaneous injection anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local anesthesia by a subcutaneous injection of a solution containing 1% Lidocaine and 0.005 mg/mL Epinephrine in the minutes before laceration repair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine-Prilocaine Cream 2.5-2.5%</intervention_name>
    <description>Topical anesthesia using a cream containing 2.5% Lidocaine and 2.5 % Prilocaine for at least 30 minutes on and around the wound before suture</description>
    <arm_group_label>Topical anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1% Epinephrine 0.005mg/mL solution</intervention_name>
    <description>Local anesthesia by subcutaneous injection of a solution containing 1% Lidocaine and 0.005mg/mL Epinephrine in and around the wound in the minutes preceding the suture of the wound</description>
    <arm_group_label>Subcutaneous injection anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Superficial skin laceration requiring a suture

        Exclusion Criteria:

          -  Known allergy to lidocaine

          -  Mucous membrane or eye wound

          -  Nose, ear or perineal wound

          -  Active hemorrhage in the wound

          -  Dirty or infected wound

          -  Wound requiring operation room management

          -  Distracting pain in an other location

          -  Intoxicated or comatose patient

          -  Patient Under guardianship

          -  Contra-indication to Lidocaine/Prilocaine cream: hypersensitivity, glucose-6-phosphate
             deficiency, idiopathic methemoglobinemia

          -  Neurologic disorder affecting pain sensitivity

          -  Dementia

          -  Pregnancy, breast feeding, absence of contraceptive measures for women of childbearing
             age

          -  Absence of signed informed consent

          -  Inclusion in an other interventional clinical protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Fonsegrive, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier le Mans</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christelle Jadeau, PD</last_name>
    <phone>0 (33) 2 43 43 43 43</phone>
    <phone_ext>37 482</phone_ext>
    <email>cjadeau@ch-lemans.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Christophe Callahan, MD</last_name>
    <phone>0 (33) 2 43 43 43 43</phone>
    <phone_ext>37 520</phone_ext>
    <email>jccallahan@ch-lemans.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Angers</name>
      <address>
        <city>Angers</city>
        <zip>49 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Lepottier Cerruti, MD</last_name>
      <phone>0241353637</phone>
      <email>marion.lepottier@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Le Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christelle Jadeau, PD</last_name>
      <phone>0 (33) 2 43 43 43 43</phone>
      <phone_ext>37 482</phone_ext>
      <email>cjadeau@ch-lemans.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Christophe Callahan, MD</last_name>
      <phone>0 (33) 2 43 43 43 43</phone>
      <phone_ext>37 520</phone_ext>
      <email>jccallahan@ch-lemans.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>McNulty RJ, Handley TP, Devlin MF. Reducing the need for general anaesthesia in children: use of LAT gel in treating facial lacerations. Br J Oral Maxillofac Surg. 2013 Sep;51(6):e130-1. doi: 10.1016/j.bjoms.2012.04.259. Epub 2012 Jun 12.</citation>
    <PMID>22694845</PMID>
  </results_reference>
  <results_reference>
    <citation>White NJ, Kim MK, Brousseau DC, Bergholte J, Hennes H. The anesthetic effectiveness of lidocaine-adrenaline-tetracaine gel on finger lacerations. Pediatr Emerg Care. 2004 Dec;20(12):812-5.</citation>
    <PMID>15572968</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2017</study_first_submitted>
  <study_first_submitted_qc>March 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2017</study_first_posted>
  <last_update_submitted>December 31, 2017</last_update_submitted>
  <last_update_submitted_qc>December 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laceration</keyword>
  <keyword>Suture</keyword>
  <keyword>Topical anesthesia</keyword>
  <keyword>Lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Lacerations</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>EMLA</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

